Navigation Links
PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
Date:10/25/2011

ctors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, including the anticipated restructuring charge of approximately $18 million over the fourth quarter of Fiscal Year 2011 as well as the first and second quarters of Fiscal Year 2012; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.  Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2011 as filed with the SEC on August 26, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International C
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New PAREXEL Podcast Series to Deliver Clinical Development and Commercialization Thought Leadership
2. PAREXEL and National University of Singapore Establish Program in Singapore to Meet Increasing Demand in Asia for Clinical Research Talent
3. PAREXEL Announces Date of First Quarter Fiscal Year 2012 Earnings Release and Conference Call
4. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
5. PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
6. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
7. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2011 Earnings Release and Conference Call
8. PAREXEL International to Present at Goldman Sachs Healthcare Conference and Jefferies Global Healthcare Conference
9. PAREXEL Invites Public to Listen to Live Webcast of Its Investor Day June 2, 2011
10. PAREXEL Reports Third Quarter Fiscal Year 2011 Financial Results
11. Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 31, 2014  Zacks.com announces the list of stocks featured in ... the latest news and events impacting stocks and the financial markets. ... AMGN - Free Report ), Celgene (Nasdaq: CELG ... - Free Report ), Market Vectors Biotech ETF (AMEX: ... ETF (AMEX: XBI - Free Report ). ...
(Date:10/31/2014)... , October 31, 2014 Multigate Medical ... patents of B. Braun Melsungen AG (B. Braun) by selling ... safety IV catheters manufactured by Poly Medicure Ltd (Polymed). The ... proceeding number VID 463 of 2013 can be ... detailed judgment, Multigate was found to have infringed claim 1 ...
(Date:10/31/2014)... Oct. 30, 2014 Electronic prescribing ... transmission of prescription related information between prescriber, ... allows a physician and nurse practitioner to ... medication error occurs during pharmacy operations. E-Prescribing ... It provides complete medical lists, conducts all ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 2The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 3The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 4The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 5The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 6The Zacks Analyst Blog Highlights: Amgen, Celgene, Biogen Idec, Market Vectors Biotech ETF and SPDR S&P Biotech ETF 7B. Braun Wins Patent Disputes Against Poly Medicure Ltd's Australian Distributor Multigate Medical Devices Pty. Ltd. and Spanish Distributor Dextromédica S. L. 2E-Prescribing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 2
... Building Comprehensive HIV/AIDS Care Programs in,Resource-Limited Settings" ... Health,Experts, MEXICO CITY, Aug. 5 ... from the "A Day in the Life ... and others, unveiled today a comprehensive guide ...
... and safety of once-daily TMC278 in ... treatment-naive adults with HIV-1 ... IIb data from Tibotec,Pharmaceuticals Ltd. provides additional information on ... reverse transcriptase inhibitor (NNRTI), as part of HIV,combination therapy ...
Cached Medicine Technology:Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 2Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City 3Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2
(Date:10/31/2014)... Daily Gossip writes in its Xtreme Fat Loss review that ... loss program ever developed. It promises to provide users the ... no wonder after all that this has become the most ... and workout fat loss program was created by Joel Marion, ... the author of this fat loss system, the method can ...
(Date:10/31/2014)... Activz Whole-Food Nutrition is ... line offering natural silver healing support† in liquid supplements, ... silver has been used to support natural healing, and ... the most advanced version available. This latest formula, backed ... that supports the existing healing mechanisms in the human ...
(Date:10/31/2014)... terms of duration of treatment and cost, patients ... accelerated partial breast irradiation (APBI) with proton therapy ... research from The University of Texas MD Anderson ... cost analysis study based on typical patient characteristics, ... charges for eight different types of partial and ...
(Date:10/31/2014)... The Suspension Revolution review published by Daily ... by Dan Long, a suspension training specialist. , ... and life coach. The author of this program claims ... not impossible , The Suspension Revolution review reveals that ... promises efficiency when it comes to burning fat, building ...
(Date:10/31/2014)... New York, NY (PRWEB) October 31, 2014 ... on one of the most remarkable gifts of life ... a platform for matching extraordinary surrogate mothers and donors ... stories about individuals in unforeseen circumstances. , It’s a ... sperm donors, surrogacy agencies, surrogacy lawyers, and fertility clinics ...
Breaking Medicine News(10 mins):Health News:Xtreme Fat Loss Diet Review Reveals How to Transform Your Body in 25 Days 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Suspension Revolution Review Reveals Dan Long's New Suspension Workout Plan 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
... the rage among doctors treating patients with blocked arteries, ... link them with a low, but serious risk of ... research by American scientists in two different studies published ... that many doctors have stretched the limit of their ...
... recalling 1.75 quart cartons of Mayfield Turtle Tracks ice cream ... code of 75243-20120. The recall was initiated because the affected ... No other Mayfield Dairy Farms products are involved in this ... the risk of a serious reaction if they consume this ...
... may be the most promising area of research for ... according to a new review in the International Journal ... confirmed the role of hormone therapy in recurrent ovarian ... review author Dr. Siqing Fu, an assistant professor of ...
... its efforts to prevent the spread of drug-resistant ... the public health sector and providing health care ... Skweyiya said at a media briefing on Tuesday, ... that the country is expanding hospital isolation wards ...
... Ministry of External Affairs, informed the Lok Sabha today that ... passports. ,At first these passports will be ... the end of 2007. Based on the experience gained from this ... the ordinary category by the end of 2008. , ...
... the thought that doctors could be on the payrolls of ... rampant in many developing countries. But things are no difference ... repeated visits by representatives of pharmaceutical firms resulted in prescription ... venerable New York Times wrote, doctors who have close relationships ...
Cached Medicine News:Health News:Studies Reveal Inappropriate Use Of Drug-Coated Stents 2Health News:Studies Reveal Inappropriate Use Of Drug-Coated Stents 3Health News:South Africa Increasing Efforts To Contain Drug-Resistant TB, Minister Says 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 2Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 3Health News:Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics 4
... is a neurosurgical OR that fully ... tools, including iMRI, necessary to treat ... neurosurgical treatments are performed in a ... for MR compatibility and safety, BrainSUITE ...
... Quality EEG recording is assured even in ... has high performance, high sensitivity amplifiers, ... rejection filter, shielded electrodes and a high ... Neurofax is a complete and ready ...
... the world's first Windows 2000 notebook ... It allows data sharing with other ... with Microsoft Office 2000. Data and ... the large, sharp 14.1-inch TFT screen ...
... Physiological lesion assessment using Fractional ... proven and cost effective solution ... location of stenosis). Radi's new ... offer fast, easy and accurate ...
Medicine Products: